The present invention relates to a solid phase pharmaceutical composition comprising one or more pharmaceutically acceptable excipients and an active pharmaceutical ingredient ("API") which is a compound of formula A1 or A2 or a pharmacologically acceptable salt solvate or hydrate thereof wherein the API is not exposed to a basic compound.
